Prelude Capital Management’s Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 TRCA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,337
Closed -$6K 2381
2021
Q4
$6K Buy
+10,337
New +$7.33K ﹤0.01% 1948

Other funds holding TRCA.WS

Prelude Capital Management's TRCA.WS Position: Q1 2022 in Review

Prelude Capital Management sold out of Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (TRCA.WS) in Q1 2022, closing a stake of 10,337 shares — an estimated $6K sold.

Prelude Capital Management first reported a position in TRCA.WS in Q4 2021 and held it in 1 quarter. The position peaked at $6K in Q4 2021. 33 funds tracked by Wall St. Rank hold TRCA.WS as of Q1 2022.

  • Prelude Capital Management reported no remaining Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q1 2022 after selling out during the quarter.
  • Prelude Capital Management sold 10,337 Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q1 2022, an estimated $6K.
  • Prelude Capital Management first reported a position in Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q4 2021 and held it in 1 quarter.
  • Prelude Capital Management's Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $6K in Q4 2021.
  • 33 funds tracked by Wall St. Rank held Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q1 2022.

Based on Prelude Capital Management's 13F filing for Q1 2022, filed 16 May 2022.